Stockreport

Orion Pharma initiates TEADCO Phase 1b/2 basket trial evaluating ODM-212 in combination with standard of care treatments in patients with select advanced solid tumours

ORION CORP NEW UNSP/ADR  (ORINY) 
PDF ORION CORPORATION PRESS RELEASE 23 APRIL 2026 at 09.00 EEST         Orion Pharma initiates TEADCO Phase 1b/2 basket trial evaluating ODM-212 in combination with stand [Read more]